CD4+ T cells, long regarded as supporting actors in cancer immunity, are emerging as central regulators of tumor control and ...

A personalized peptide vaccine slashed prostate-specific antigen levels by as much as 99.6% in some men with advanced prostate cancer, according to a phase II clinical trial conducted at Kurume ...

Cancer immunotherapy has transformed oncology, yet many patients fail to respond or eventually develop resistance.

As immunotherapy becomes a cornerstone of cancer treatment, some of the top U.S. cancer centers and health systems are accelerating research efforts to identify the biological mechanisms behind ...

Find out how immunotherapy can improve cancer treatment outcomes and the systemic barriers limiting its widespread use.

Generally, the standard treatment for solid tumors is surgery. However, a recent study from New York City-based Memorial Sloan Kettering Cancer Center found immunotherapy can effectively treat these ...

The below is a summary of a story that originally appeared on the Duke Health News website. Immunotherapy has transformed cancer care by helping the immune system recognize and destroy tumors. But new ...

Immune checkpoint inhibitors targeting PD-1 and PD-L1 have revolutionized cancer therapy, delivering long-term survival benefits in several malignancies. However, nearly half of patients show limited ...

This schematic illustrates stratification of gastrointestinal tract cancers based on their sensitivity to immunotherapy, thereby dictating distinct therapeutic paradigms that guide clinical ...

Explore the latest colorectal cancer treatment advances, from precision oncology and immunotherapy to ADCs, bispecifics, and ...